跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FEMARA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FEMARA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
FEMARA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Novartis Hellas S.A.C.I.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 31, 2025
Approval ID
7aa5efd1b18b5f91
Company
Novartis Hellas S.A.C.I.
Type
Standard
Approval Details
Approval Id
7aa5efd1b18b5f91
Drug Cima Aemps Name
FEMARA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
837871425042018IP
Holder Company Name
Novartis Hellas S.A.C.I.
Marketing Company Name
Abacus Medicine A/S
Authorization Date
2025-01-31
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
2.5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Novartis Hellas S.A.C.I.
Active Ingredients
LETROZOL
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 31, 2025
Approval ID
7aa5efd1b18b5f91
Type
Standard
Back to CIMA-AEMPS Approvals
